Laboratory Monitoring of the Non-Vitamin K Oral Anticoagulants

被引：24

作者：

Blann, Andrew D. ^{[1
]}

Lip, Gregory Y. H. ^{[1
]}

机构：

[1] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 11期

关键词：

apixaban; coagulation tests; dabigatran; monitoring; non-vitamin K oral anticoagulant (NOAC); rivaroxaban; DABIGATRAN ETEXILATE; ATRIAL-FIBRILLATION; COAGULATION ASSAYS; RIVAROXABAN;

D O I：

10.1016/j.jacc.2014.07.010

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1140 / 1142

页数：3

共 11 条

[1]

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology [J].

Baglin, Trevor ;

Keeling, David ;

Kitchen, Steve .

BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (04) :427-429

[2]

Laboratory Measurement of the Anticoagulant Activity of the Non-Vitamin K Oral Anticoagulants [J].

Cuker, Adam ;

Siegal, Deborah M. ;

Crowther, Mark A. ;

Garcia, David A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) :1128-1139

[3]

Cushman M., 2014, CLIN PRACTICE GUIDE

[4]

General mechanisms of coagulation and targets of anticoagulants (Section I) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease [J].

De Caterina, Raffaele ;

Husted, Steen ;

Wallentin, Lars ;

Andreotti, Felicita ;

Arnesen, Harald ;

Bachmann, Fedor ;

Baigent, Colin ;

Huber, Kurt ;

Jespersen, Jorgen ;

Kristensen, Steen Dalby ;

Lip, Gregory Y. H. ;

Morais, Joao ;

Rasmussen, Lars Hvilsted ;

Siegbahn, Agneta ;

Verheugt, Freek W. A. ;

Weitz, Jeffrey I. .

THROMBOSIS AND HAEMOSTASIS, 2013, 109 (04) :569-579

[5]

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate [J].

Douxfils, Jonathan ;

Dogne, Jean-Michel ;

Mullier, Francois ;

Chatelain, Bernard ;

Ronquist-Nii, Yuko ;

Malmstrom, Rickard E. ;

Hjemdahl, Paul .

THROMBOSIS AND HAEMOSTASIS, 2013, 110 (03) :543-549

[6]

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation [J].

Heidbuchel, Hein ;

Verhamme, Peter ;

Alings, Marco ;

Antz, Matthias ;

Hacke, Werner ;

Oldgren, Jonas ;

Sinnaeve, Peter ;

Camm, A. John ;

Kirchhof, Paulus .

EUROPACE, 2013, 15 (05) :625-651

[7]

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays [J].

Hillarp, A. ;

Baghaei, F. ;

Blixter, I. Fagerberg ;

Gustafsson, K. M. ;

Stigendal, L. ;

Sten-Linder, M. ;

Strandberg, K. ;

Lindahl, T. L. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (01) :133-139

[8]

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice [J].

Huisman, Menno V. ;

Lip, Gregory Y. H. ;

Diener, Hans-Christoph ;

Brueckmann, Martina ;

van Ryn, Joanne ;

Clemens, Andreas .

THROMBOSIS AND HAEMOSTASIS, 2012, 107 (05) :838-847

[9]

Husted S, 2014, THROMB HAEMOSTASIS, V111, P781

[10]

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls [J].

Samama, Meyer Michel ;

Contant, Genevieve ;

Spiro, Theodore E. ;

Perzborn, Elisabeth ;

Guinet, Celine ;

Gourmelin, Yves ;

Le Flem, Lena ;

Rohde, Gabriele ;

Martinoli, Jean Luc .

THROMBOSIS AND HAEMOSTASIS, 2012, 107 (02) :379-387

← 1 2 →